Skip to content
naulon

Not checkedNot checked for notices yet.

Revisiting IDO and its value as a predictive marker for anti-PD-1 resistance

Peter Kim Moon, Stephanie Tran, Paras Singh Minhas

Journal of Translational Medicine · 2019

doi:10.1186/s12967-019-1784-8 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Abstract Botticelli et al. proposed the activity of indoleamine-2,3-dioxygenase 1 (IDO) as a potential mechanism and predictive marker for primary resistance against anti-PD-1 treatment in the context of non-small cell lung cancer. However, there are a few points for the authors to address in order to strengthen their claims. First, there are many enzymes that modulate the kynurenine to tryptophan ratio, thereby calling into question their use of the ratio as a proxy for IDO activity. Second, the authors could compare IDO to other proposed markers in the literature, providing a better understanding of its predictive value.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.